SSMXY News Alert Sysmex Corp ADR (SSMXY) 23.0600 02/15/2015
Post# of 64074
Posted On: 02/15/2015 3:16:08 PM
Sysmex Corp ADR (SSMXY) 23.0600 $SSMXY
Bio-AMD, Inc. Agreement with Sysmex & General Update
ACCESSWIRE - Tue Jan 27, 7:46AM CST
LONDON, ENGLAND / ACCESSWIRE / January 27, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"
(OTCQB: BIAD) provides an update on the Company's plans for 2015.
Bio-AMD, Inc.; Agreement with Sysmex and General Update
eTeligis - Tue Jan 27, 7:30AM CST
LONDON, United Kingdom, via ETELIGIS INC., 01/27/2015 - - Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company" (OTCQB: BIAD) provides an update on the Company's plans for 2015.
Blood Coagulation Analyzer - 2015 Product Analysis from 17 Blood Coagulation Analyzer Manufacturers
M2 - Fri Jan 23, 9:26PM CST
Research and Markets (http://www.researchandmarkets.com/research/t3r77w/blood_coagulation) has announced the addition of the "Blood Coagulation Analyzer - Product Analysis" report to their offering. This 125 page report "Blood Coagulation Analyzer - Product Analysis" contains 4 figures and 40 Tables provides a comprehensive assessment of the blood coagulation products of the companies. It examines the latest available and emerging coagulation tests and products being utilized by the coagulation testing field and describes the current product lines of almost all of the companies known to be marketing and manufacturing instruments for blood coagulation testing. Each company is discussed in depth with a section on its product line, sales figures and a competitive/comparative tests and product analysis of the company. All the Blood Coagulation Analyzers in the report have been studied from 5 viewpoints: 1. Analyzer Benefits and Features 2. Specifications 3. Net Product Sales 4. Companies - Comparative Tests Analysis 5. Competitive Product Analysis Key Topics Covered: 1. Executive Summary 2. Blood Coagulation Analyzer Companies - Comparative Tests Analysis 3. Blood Coagulation Analyzer - Competitive Product Analysis 4. Alere 5. Siemens Healthcare 6. Sysmex Corporation 7. Coag - Sense 8. Abbott Laboratories Point of Care 9. International Technidyne Corporation 10. Instrumentation Laboratory 11. Roche 12. DiagnosticaStago 13. Tcoag 14. Sekisui Medical Co. Ltd 15. A&T Corporation 16. Prokan 17. Analyticon 18. Sinduri Biotech 19. Helena Laboratories 20. LABiTec GmbH For more information visit http://www.researchandmarkets.com/research/t3...oagulation
ABT: 46.09 (+0.87)
Asia-Pacific Clinical Chemistry Market 2013-2018
M2 - Wed Dec 17, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz9p48/micro_market) has announced the addition of the "Micro Market Monitor: Asia-Pacific Clinical Chemistry Market" report to their offering. The market in this region is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1,047.2 million by 2018, at a CAGR of 16% from 2013 to 2018. The Asia-Pacific clinical chemistry market is growing due to the ongoing developments in analytical laboratory automation, the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology, and finally, the geographical market expansion within emerging countries. The major changes in clinical chemistry have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, new technologies have enabled a better understanding of disease processes. The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview Companies Mentioned - Abbott Diagnostics Inc. - Beckman Coulter Inc. (Subsidiary Of Danaher Corporation) - Fujifilm Holdings Corporation - Hitachi Ltd - Horiba Ltd - Mindray Medical International Limited - Orthoclinical Diagnostics - Randox Laboratories - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific Inc. - Toshiba Corporation - Transasia Bio-Medicals Ltd. For more information visit http://www.researchandmarkets.com/research/mz...cro_market
DHR: 86.81 (+0.21), MR: 27.19 (+0.15)
Global In Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020 - Revenue is Expected to Reach $74.65 Billion
M2 - Wed Nov 26, 2:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/8l3wrm/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market. Widespread knowledge of healthcare & its benefits, and cost effectiveness are some top impacting factors of the global IVD market. The stringent regulatory policies and reimbursement issues are limiting the growth of the market. Furthermore, the rising demand for technologically advanced diagnosis devices and increased spending capabilities of consumers on health care provides huge potential for IVD in Asia Pacific market. Scope of the Report KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS - Others MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others Companies mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/8l...l_in_vitro
JNJ: 99.62 (+1.18), BDX: 143.71 (+0.72), ALR: 43.40 (-0.40)
Global In-Vitro Diagnostics Market - Trends & Forecast to 2020
M2 - Thu Nov 20, 5:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/pgnmpm/global_invitro) has announced the addition of the "Global In-Vitro Diagnostics Market - Trends & Forecast to 2020" report to their offering. The global IVD market is expected to grow at a CAGR of more than 6% from 2014 to 2020 to reach a market size of more than $90 billion by the end of 2020 In the report, the IVD market has been segmented on the basis of techniques, products, applications, and end-users. The market assessment of the above mentioned segments is made across the geographies such as North America, Europe, Asia-Pacific, LATAM and MENA. Major factors such as technological advancements in the diagnostics, and rising healthcare awareness, increased incidence of chronic and infectious disease, demand for POCT devices are boosting the market growth However, intensified competition, reimbursement issues, and affordability of healthcare diagnostics are hindering the IVD market growth. The global IVD market by technique is segmented into clinical chemistry, Immunochemistry or Immunoassay, haematology, coagulation, microbiology, molecular diagnostics and other clinical instruments. Immunochemistry or Immunoassay accounted for the largest share in 2013 and is growing at a steady pace. Whereas, molecular diagnostics market segment is expected to register the highest CAGR of more than 9% from 2014 to 2020. IVD products market is categorized based on instruments, reagents, data management software/hardware and services. Reagents market commanded the largest share in 2013 and is expected to grow at the highest CAGR of more than 7% during the forecast period. The global IVD market by application is segmented into infectious disease, oncology, diabetes, cardiology, nephrology, autoimmune disease, HIV/AIDS, drug testing, and others. Infectious disease commanded the largest share in 2013 and is expected to grow strong, whereas oncology segment is expected to register the highest CAGR during the forecast period. IVD market by end-users is sub segmented into laboratory, hospitals, academics and patient self-testing. Hospital accounted for the largest market of $25.5 billion in 2013 and is expected to reach $41.9 billion by 2020 at a CAGR of 6.4%. Key Topics Covered: 1. Summary 2. Introduction 3. Market Overview 4. Global IVD market by Products 5. Global IVD market by Techniques 5. Global IVD market by Applications 6. Global IVD market by End-users 7. Geographic Analysis 8. Competitors Landscape 9. Major Player Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/pg...al_invitro
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), DHR: 86.81 (+0.21)
Immunoassay Systems - 2014 Global Strategic Business Report: Automated Multiplexing Platforms Present Growth Opportunities
M2 - Tue Oct 28, 4:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rm7vvd/immunoassay) has announced the addition of the "Immunoassay Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: - Enzyme Immunoassay Systems - Fluorescence Immunoassay Systems - Chemiluminescence Immunoassay Systems - Radio Immunoassay Systems - Nephelometric Immunoassay Systems The report profiles 80 companies including many key and niche players such as: - Abbott Laboratories - Beckman Coulter, Inc. - bioM?rieux SA - Bio-Rad Laboratories Inc. - Ortho-Clinical Diagnostics Inc - Roche Diagnostics - Siemens Healthcare Diagnostics - Sysmex Corporation - Quidel Corporation - DiaSorin S.p.A - Fujirebio Inc. - Tosoh Bioscience, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Competitive Landscape 3. Market Trends And Issues 4. An Insight Into Immunoassay Technologies 5. Immunoassay Applications - A Review 6. Conceptual Overview 7. Medical Diagnostics Market - A Review 8. Product Launches/Approvals 9. Recent Industry Activity 10. Focus On Select Market Participants 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 80 (including Divisions/Subsidiaries - 104) - The United States (60) - Canada (2) - Japan (
- Europe (30) - - France (2) - - Germany ( - - The United Kingdom (6) - - Italy (4) - - Spain (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (3) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/rm...mmunoassay
ABT: 46.09 (+0.87)
WHX, SSMXY, JALA, Removed From Naked Short Lists Today
M2 - Thu Oct 02, 9:02AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Removed From the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Whiting USA Trust (NYSE:WHX), (OTC:SSMXY), (OTC:JALA). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
WHX: 0.61 (+0.06)
WHX, SSMXY, JALA, Added To Naked Short Lists Today
M2 - Thu Sep 25, 9:03AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Whiting USA Trust (NYSE:WHX), (OTC:SSMXY), (OTC:JALA). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
WHX: 0.61 (+0.06)
Global In-Vitro Diagnostics (POC/Rapid Diagnostics) Market 2014-2020
M2 - Mon Sep 22, 3:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kjf5z9/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020" report to their offering. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, near-patient testing, self-testing. IVD market is segmented by-techniques (including immunoassays, point of care, molecular diagnostics, hematology, coagulation, microbiology, clinical techniques, microbiology), product-type (including instruments, reagents, services, data management systems), usability (including disposable, reusable), applications (including diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug testing), -end-user (including hospitals, laboratories, academics) and geography (globally). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Global Ivd Market, By Technique 5. Global Ivd Market, By Products 6. Global Ivd Market, By Application 7. Global Ivd Market, By End-Users 8. Regional Market Analysis 9. Company Developments 10. Major Player Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/kjf5z9/in_vitro
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), DHR: 86.81 (+0.21)
Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 8:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdwv9t/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices. Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates. The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications. Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period.The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment. The report showcases top players such as: - Abbot Laboratories - Roche Diagnostics - Siemens - Johnson & Johnson - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Sysmex Corp KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others For more information visit http://www.researchandmarkets.com/research/sd...l_in_vitro
JNJ: 99.62 (+1.18), BDX: 143.71 (+0.72), ALR: 43.40 (-0.40)
The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition (2014)
M2 - Wed Aug 27, 3:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x2f378/the_worldwide) has announced the addition of the "The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" report to their offering. This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a tremendous value. Used by Top IVD Companies For Business Planning. This is the ninth edition of this informative volume based on the market events of 2013 and early 2014. New entrants, new technologies have entered the stage and all important events are cataloged in this report. The idea behind Kalorama's unique report is that the entire market can be captured in one volume. This volume includes market estimates for 2013 base year and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including: - Core Lab (General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care) - Point of Care (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other) - Histology and Cytology (Pap, ISH, IHC, HPV) - Lab-based Infectious Disease Immunoassays, by Test (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others) - Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal) - Hematology - Molecular Test Sales, Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others - Lab-based Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D) - Coagulation (Lab-Based, POC, Genetic Markers) - Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies) - Blood Banking (Grouping, Immunoassay Screens, NAT Screens) At 1200 pages, this is the most comprehensive report on the in vitro diagnostic industry available. No surprise that it has been called the 'Bible of the IVD Industry' by past users of the report. Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Overview of Global In Vitro Diagnostic Markets Chapter Four: Trends and Innovation Chapter Five: Point-Of-Care Tests Chapter Six: the Core Lab Chapter Seven: Immunoassays Chapter Eight: Molecular Assays Chapter Nine: Hematology Chapter Ten: Coagulation Chapter Eleven: Microbiology and Virology Chapter Twelve: Blood Banking Services Chapter Thirteen: Histology/Cytology Chapter Fourteen: Company Profiles Companies Mentioned - Abbott Diagnostics - Alere Inc. - Arkray - Beckman Coulter, Inc. - Becton, Dickinson and Company (BD) - bioM?rieux Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hologic, Inc. - Ortho Clinical Diagnostics (OCD) - QIAGEN N.V. - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific Inc. - Cepheid - Eiken Chemical Co., Ltd - ERBA Diagnostics, Inc. - DiaSorin S.p.A - Fujirebio Diagnostics, Inc. - Illumina - LabCorp - Luminex Corporation - Menarini Diagnostics - Myriad Genetics - PerkinElmer, Inc. (PE) - Quest Diagnostics - Quidel Corporation - Randox Laboratories Ltd. - TOSOH Corporation - Wako Pure Chemical Industries And hundreds of other companies... For more information visit http://www.researchandmarkets.com/research/x2..._worldwide
MYGN: 34.03 (+0.40), ALR: 43.40 (-0.40), DHR: 86.81 (+0.21), LMNX: 15.45 (+0.02), ERB: 3.45 (-0.09), PKI: 46.30 (-0.10), DGX: 71.68 (+0.03), CPHD: 59.62 (+0.72), QGEN: 23.68 (-0.06), HOLX: 30.46 (+0.21)
Hematology Instruments and Reagents - 2014 Global Strategic Business Report
M2 - Thu Aug 21, 2:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz4292/hematology) has announced the addition of the "Hematology Instruments and Reagents - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Hematology Instruments and Reagents in US$ Thousands by the following Product Segments: - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, & Hematology Vials) - Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, & Hematology Stains). The report profiles 78 companies including many key and niche players such as: - Abbott Diagnostics, Inc. - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Drucker Diagnostics - Horiba Ltd. - Instrumentation Laboratory, Inc. - Mindray Medical International Limited - Roche Diagnostics - Siemens Healthcare - Sigma-Aldrich Corporation - Stago - Sysmex Corporation - Sysmex America, Inc. - Tcoag Ireland Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview & Trends 3. Competitive Scenario 4. Key Product Segments 5. Blood The All Pervasive Connective Tissue 6. Hematology The Core Idea 8. Blood Testing Developments A Historic Review 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 78 (including Divisions/Subsidiaries 111) - The United States (40) - Japan (10) - Europe (37) - France (7) - Germany ( - The United Kingdom (5) - Italy (3) - Spain (2) - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (22) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/fz4292/hematology
SIAL: 138.20 (+0.07), MR: 27.19 (+0.15)
Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report 2014
M2 - Thu Aug 07, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4mlqf7/circulating) has announced the addition of the "Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report" report to their offering. The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The report will also provide a market analysis of the market value, growth rates, market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry players, and the factors influencing the market shares of both the major market suppliers and smaller indigenous manufacturers in local markets. The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models. The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis. Key Topics Covered: Executive Summary Chapter 1: Introduction to the Circulating Nucleic Acid Market Report Chapter 2: Background to Circulating Nucleic Acids Chapter 3: Cancer: A Statistical Analysis of the Disease Incidence and Prevalence Chapter 4: CNA Based Cancer Diagnostics Market: Revenue Analysis Chapter 5: CNA Based Cancer Diagnostics Market: Market Share Analysis Chapter 6: Company Profiles - Abbott Laboratories (Abbott Molecular) - Affymetrix Inc - Autogenomics - Becton Dickinson and Company (BD) - Beckmann Coulter, Inc (Danaher Corporation) - bioM?rieux - Cancer Genetics, Inc - Cepheid - Dako (Agilent) - Epigenomics - Hologic Gen-Probe - Illumina - Ipsogen (Qiagen) - Luminex - MolecularMD - Myriad Genetics Laboratories - Novartis Diagnostics - Ortho-Clinical Diagnostics (The Carlyle Group) - Oxford Gene Technology (OGT) - Qiagen N.V. - Roche - Siemens - Sysmex Corporation - Thermo Fisher Scientific - Ventana (Roche) - For more information visit http://www.researchandmarkets.com/research/4m...irculating
ABT: 46.09 (+0.87), MYGN: 34.03 (+0.40), CPHD: 59.62 (+0.72), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21), CGIX: 7.07 (unch), AFFX: 11.45 (+0.02), NVS: 102.20 (-0.17)
Hematology Analyzers & Reagents Market - Forecasts to 2019
M2 - Wed Jul 30, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gc4hs3/hematology) has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering. The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions. In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Trends 6 Hematology Products and Services Market 7 Global Hematology Market, By End Users 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Bio-Rad Laboratories - Boule Diagnostics Ab - Horiba, Ltd. - Mindray Medical International Limited - Nihon Kohden Corporation - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/gc4hs3/hematology
ABT: 46.09 (+0.87), MR: 27.19 (+0.15)
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer
PR Newswire - Wed Jul 23, 7:44PM CDT
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw's appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation's president and governing board while maintaining his leadership position with Sysmex America.
United States Market for In Vitro Diagnostic Tests Report 2014-2018
M2 - Wed Jul 23, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x885q3/the_united_states) has announced the addition of the "The United States Market for In Vitro Diagnostic Tests" report to their offering. Advanced flow cytometry and microbiology tests will provide more opportunity for manufacturers than POC tests or clinical chemistry test products sold in the United States. A Relative Opportunity Metric is used to assess the segments of clinical lab testing in the world's largest healthcare market. According to the report, Market growth remains robust for U.S. microbiology diagnostics, a group of IVD segments including traditional microbiology (culturing for ID/AST), rapid tests, molecular infectious disease tests, and immunoassay infectious disease tests. Several market drivers exist for microbiology in the United States: hospital investment in microbiology for health-acquired infection (HAI) testing, investment in automated microbiology systems, rising rates of incidence for several sexually transmitted diseases (STDs), and market penetration by higher-priced molecular infectious disease tests. The report also indicates that advanced IVD tests in this study, including molecular assays for non-infectious disease testing, histology, cytology, and flow cytometry. Molecular assays and histology are projected to be the two-fastest growing IVD market segments in the United States through 2018. Tissue analysis or histology in support of cancer diagnosis and treatment is increasingly reliant on immunohistochemical (IHC) reagents and molecular hybridization (ISH/FISH) techniques and represents a fast rising market in the aging United States. The United States is also ground zero for an influx of advanced molecular assays for blood-based cancer testing, circulating tumor cell (CTC) testing, pharmacodiagnostics, and other sequencing-developed tests. The report, The United States Market for In Vitro Diagnostic Tests, contains further detail on the US IVD market including segment markets and forecasts, corporate profiles, and other information. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction To U.S. Health Care Chapter Three: U.S. Ivd Market Analysis Chapter Four: Top Tier U.S. Ivd Market Players - Abbott Diagnostics - Alere - Beckman Coulter - Becton Dickinson - Danaher Corporation - Hologic - Ortho-Clinical Diagnostics / J&J Diabetes Care - QIAGEN - Roche Diagnostics - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x8...ted_states
DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)
In Vitro Diagnostics (POC/Rapid Diagnostics) Global Market - Forecast to 2019
M2 - Mon Jul 21, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8h8cv2/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2019" report to their offering. The Asia-Pacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region. IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth. Roche diagnostics (Basel, Switzerland) is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.), bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and R&D units in China to grow IVD market. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. IVD market by Techniques 5. IVD market by Products 6. IVD market by Applications 7. IVD market by End-users 8. IVD market by Usability 9. Regional Market Analysis 10. Company Developments 11. Major Company Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/8h8cv2/in_vitro
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21)
US Hematology Diagnostics Market to 2017
M2 - Wed Jul 02, 8:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hb8k3j/us_hematology) has announced the addition of the "US Hematology Diagnostics Market" report to their offering. This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician's office laboratories. Key Questions This Study Will Answer: - Is the market growing, how long will it continue to grow, and at what rate? - Are the existing competitors structured correctly to meet customer needs? - How will the structure of the market change over time? Is it ripe for acquisitions? - Which emerging or anticipated companies should be on competitors' radar, and why? - Are the products/services offered today meeting customer needs, or is additional development needed? - Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. Drivers, Restraints, and TrendsTotal Hematology Diagnostics Market 5. Forecast and TrendsTotal Hematology Diagnostics Market 6. Competitive Environment 7. Product Analysis 8. Hematology Analyzers Segment 9. Hematology Reagents Segment 10. The Last Word 11. Appendix Companies Mentioned - Abbott Diagnostics - Beckman Coulter - Biorad - Horiba ABX - Medica - Mindray - Siemens Diagnostics - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/hb...hematology
Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020
M2 - Fri Jun 27, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xm2bw/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020" report to their offering. According to this research report titled "In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020). The IVD market is evolving in the emerging markets due to widespread healthcare awareness and increased spending capabilities of people on healthcare. In addition, high demand of technologically advanced equipment for the early and precise diagnosis of various diseases is further strengthening the market growth in such regions. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL IVD MARKET BY TECHNIQUES CHAPTER 5 GLOBAL IVD MARKET BY PRODUCT TYPE CHAPTER 6 GLOBAL IVD MARKET BY USABILITY CHAPTER 7 GLOBAL IVD MARKET BY APPLICATION CHAPTER 8 GLOBAL IVD MARKET BY END USERS CHAPTER 9 GLOBAL IVD MARKET BY GEOGRAPHY CHAPTER 10 COMPANY PROFILES Companies Mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/9x...l_in_vitro
JNJ: 99.62 (+1.18), BDX: 143.71 (+0.72), ALR: 43.40 (-0.40)
Bio-AMD, Inc. Agreement with Sysmex & General Update
ACCESSWIRE - Tue Jan 27, 7:46AM CST
LONDON, ENGLAND / ACCESSWIRE / January 27, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"
(OTCQB: BIAD) provides an update on the Company's plans for 2015. Bio-AMD, Inc.; Agreement with Sysmex and General Update
eTeligis - Tue Jan 27, 7:30AM CST
LONDON, United Kingdom, via ETELIGIS INC., 01/27/2015 - - Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"
(OTCQB: BIAD) provides an update on the Company's plans for 2015. Blood Coagulation Analyzer - 2015 Product Analysis from 17 Blood Coagulation Analyzer Manufacturers
M2 - Fri Jan 23, 9:26PM CST
Research and Markets (http://www.researchandmarkets.com/research/t3r77w/blood_coagulation) has announced the addition of the "Blood Coagulation Analyzer - Product Analysis" report to their offering. This 125 page report "Blood Coagulation Analyzer - Product Analysis" contains 4 figures and 40 Tables provides a comprehensive assessment of the blood coagulation products of the companies. It examines the latest available and emerging coagulation tests and products being utilized by the coagulation testing field and describes the current product lines of almost all of the companies known to be marketing and manufacturing instruments for blood coagulation testing. Each company is discussed in depth with a section on its product line, sales figures and a competitive/comparative tests and product analysis of the company. All the Blood Coagulation Analyzers in the report have been studied from 5 viewpoints: 1. Analyzer Benefits and Features 2. Specifications 3. Net Product Sales 4. Companies - Comparative Tests Analysis 5. Competitive Product Analysis Key Topics Covered: 1. Executive Summary 2. Blood Coagulation Analyzer Companies - Comparative Tests Analysis 3. Blood Coagulation Analyzer - Competitive Product Analysis 4. Alere 5. Siemens Healthcare 6. Sysmex Corporation 7. Coag - Sense 8. Abbott Laboratories Point of Care 9. International Technidyne Corporation 10. Instrumentation Laboratory 11. Roche 12. DiagnosticaStago 13. Tcoag 14. Sekisui Medical Co. Ltd 15. A&T Corporation 16. Prokan 17. Analyticon 18. Sinduri Biotech 19. Helena Laboratories 20. LABiTec GmbH For more information visit http://www.researchandmarkets.com/research/t3...oagulation
ABT: 46.09 (+0.87)
Asia-Pacific Clinical Chemistry Market 2013-2018
M2 - Wed Dec 17, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz9p48/micro_market) has announced the addition of the "Micro Market Monitor: Asia-Pacific Clinical Chemistry Market" report to their offering. The market in this region is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1,047.2 million by 2018, at a CAGR of 16% from 2013 to 2018. The Asia-Pacific clinical chemistry market is growing due to the ongoing developments in analytical laboratory automation, the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology, and finally, the geographical market expansion within emerging countries. The major changes in clinical chemistry have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, new technologies have enabled a better understanding of disease processes. The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview Companies Mentioned - Abbott Diagnostics Inc. - Beckman Coulter Inc. (Subsidiary Of Danaher Corporation) - Fujifilm Holdings Corporation - Hitachi Ltd - Horiba Ltd - Mindray Medical International Limited - Orthoclinical Diagnostics - Randox Laboratories - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific Inc. - Toshiba Corporation - Transasia Bio-Medicals Ltd. For more information visit http://www.researchandmarkets.com/research/mz...cro_market
DHR: 86.81 (+0.21), MR: 27.19 (+0.15)
Global In Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020 - Revenue is Expected to Reach $74.65 Billion
M2 - Wed Nov 26, 2:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/8l3wrm/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market. Widespread knowledge of healthcare & its benefits, and cost effectiveness are some top impacting factors of the global IVD market. The stringent regulatory policies and reimbursement issues are limiting the growth of the market. Furthermore, the rising demand for technologically advanced diagnosis devices and increased spending capabilities of consumers on health care provides huge potential for IVD in Asia Pacific market. Scope of the Report KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS - Others MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others Companies mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/8l...l_in_vitro
JNJ: 99.62 (+1.18), BDX: 143.71 (+0.72), ALR: 43.40 (-0.40)
Global In-Vitro Diagnostics Market - Trends & Forecast to 2020
M2 - Thu Nov 20, 5:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/pgnmpm/global_invitro) has announced the addition of the "Global In-Vitro Diagnostics Market - Trends & Forecast to 2020" report to their offering. The global IVD market is expected to grow at a CAGR of more than 6% from 2014 to 2020 to reach a market size of more than $90 billion by the end of 2020 In the report, the IVD market has been segmented on the basis of techniques, products, applications, and end-users. The market assessment of the above mentioned segments is made across the geographies such as North America, Europe, Asia-Pacific, LATAM and MENA. Major factors such as technological advancements in the diagnostics, and rising healthcare awareness, increased incidence of chronic and infectious disease, demand for POCT devices are boosting the market growth However, intensified competition, reimbursement issues, and affordability of healthcare diagnostics are hindering the IVD market growth. The global IVD market by technique is segmented into clinical chemistry, Immunochemistry or Immunoassay, haematology, coagulation, microbiology, molecular diagnostics and other clinical instruments. Immunochemistry or Immunoassay accounted for the largest share in 2013 and is growing at a steady pace. Whereas, molecular diagnostics market segment is expected to register the highest CAGR of more than 9% from 2014 to 2020. IVD products market is categorized based on instruments, reagents, data management software/hardware and services. Reagents market commanded the largest share in 2013 and is expected to grow at the highest CAGR of more than 7% during the forecast period. The global IVD market by application is segmented into infectious disease, oncology, diabetes, cardiology, nephrology, autoimmune disease, HIV/AIDS, drug testing, and others. Infectious disease commanded the largest share in 2013 and is expected to grow strong, whereas oncology segment is expected to register the highest CAGR during the forecast period. IVD market by end-users is sub segmented into laboratory, hospitals, academics and patient self-testing. Hospital accounted for the largest market of $25.5 billion in 2013 and is expected to reach $41.9 billion by 2020 at a CAGR of 6.4%. Key Topics Covered: 1. Summary 2. Introduction 3. Market Overview 4. Global IVD market by Products 5. Global IVD market by Techniques 5. Global IVD market by Applications 6. Global IVD market by End-users 7. Geographic Analysis 8. Competitors Landscape 9. Major Player Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/pg...al_invitro
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), DHR: 86.81 (+0.21)
Immunoassay Systems - 2014 Global Strategic Business Report: Automated Multiplexing Platforms Present Growth Opportunities
M2 - Tue Oct 28, 4:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rm7vvd/immunoassay) has announced the addition of the "Immunoassay Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: - Enzyme Immunoassay Systems - Fluorescence Immunoassay Systems - Chemiluminescence Immunoassay Systems - Radio Immunoassay Systems - Nephelometric Immunoassay Systems The report profiles 80 companies including many key and niche players such as: - Abbott Laboratories - Beckman Coulter, Inc. - bioM?rieux SA - Bio-Rad Laboratories Inc. - Ortho-Clinical Diagnostics Inc - Roche Diagnostics - Siemens Healthcare Diagnostics - Sysmex Corporation - Quidel Corporation - DiaSorin S.p.A - Fujirebio Inc. - Tosoh Bioscience, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Competitive Landscape 3. Market Trends And Issues 4. An Insight Into Immunoassay Technologies 5. Immunoassay Applications - A Review 6. Conceptual Overview 7. Medical Diagnostics Market - A Review 8. Product Launches/Approvals 9. Recent Industry Activity 10. Focus On Select Market Participants 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 80 (including Divisions/Subsidiaries - 104) - The United States (60) - Canada (2) - Japan (
- Europe (30) - - France (2) - - Germany ( - - The United Kingdom (6) - - Italy (4) - - Spain (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (3) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/rm...mmunoassay ABT: 46.09 (+0.87)
WHX, SSMXY, JALA, Removed From Naked Short Lists Today
M2 - Thu Oct 02, 9:02AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Removed From the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Whiting USA Trust (NYSE:WHX), (OTC:SSMXY), (OTC:JALA). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
WHX: 0.61 (+0.06)
WHX, SSMXY, JALA, Added To Naked Short Lists Today
M2 - Thu Sep 25, 9:03AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Whiting USA Trust (NYSE:WHX), (OTC:SSMXY), (OTC:JALA). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
WHX: 0.61 (+0.06)
Global In-Vitro Diagnostics (POC/Rapid Diagnostics) Market 2014-2020
M2 - Mon Sep 22, 3:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kjf5z9/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020" report to their offering. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, near-patient testing, self-testing. IVD market is segmented by-techniques (including immunoassays, point of care, molecular diagnostics, hematology, coagulation, microbiology, clinical techniques, microbiology), product-type (including instruments, reagents, services, data management systems), usability (including disposable, reusable), applications (including diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug testing), -end-user (including hospitals, laboratories, academics) and geography (globally). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Global Ivd Market, By Technique 5. Global Ivd Market, By Products 6. Global Ivd Market, By Application 7. Global Ivd Market, By End-Users 8. Regional Market Analysis 9. Company Developments 10. Major Player Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/kjf5z9/in_vitro
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), DHR: 86.81 (+0.21)
Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 8:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdwv9t/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices. Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates. The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications. Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period.The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment. The report showcases top players such as: - Abbot Laboratories - Roche Diagnostics - Siemens - Johnson & Johnson - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Sysmex Corp KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others For more information visit http://www.researchandmarkets.com/research/sd...l_in_vitro
JNJ: 99.62 (+1.18), BDX: 143.71 (+0.72), ALR: 43.40 (-0.40)
The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition (2014)
M2 - Wed Aug 27, 3:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x2f378/the_worldwide) has announced the addition of the "The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" report to their offering. This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a tremendous value. Used by Top IVD Companies For Business Planning. This is the ninth edition of this informative volume based on the market events of 2013 and early 2014. New entrants, new technologies have entered the stage and all important events are cataloged in this report. The idea behind Kalorama's unique report is that the entire market can be captured in one volume. This volume includes market estimates for 2013 base year and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including: - Core Lab (General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care) - Point of Care (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other) - Histology and Cytology (Pap, ISH, IHC, HPV) - Lab-based Infectious Disease Immunoassays, by Test (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others) - Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal) - Hematology - Molecular Test Sales, Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others - Lab-based Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D) - Coagulation (Lab-Based, POC, Genetic Markers) - Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies) - Blood Banking (Grouping, Immunoassay Screens, NAT Screens) At 1200 pages, this is the most comprehensive report on the in vitro diagnostic industry available. No surprise that it has been called the 'Bible of the IVD Industry' by past users of the report. Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Overview of Global In Vitro Diagnostic Markets Chapter Four: Trends and Innovation Chapter Five: Point-Of-Care Tests Chapter Six: the Core Lab Chapter Seven: Immunoassays Chapter Eight: Molecular Assays Chapter Nine: Hematology Chapter Ten: Coagulation Chapter Eleven: Microbiology and Virology Chapter Twelve: Blood Banking Services Chapter Thirteen: Histology/Cytology Chapter Fourteen: Company Profiles Companies Mentioned - Abbott Diagnostics - Alere Inc. - Arkray - Beckman Coulter, Inc. - Becton, Dickinson and Company (BD) - bioM?rieux Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hologic, Inc. - Ortho Clinical Diagnostics (OCD) - QIAGEN N.V. - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific Inc. - Cepheid - Eiken Chemical Co., Ltd - ERBA Diagnostics, Inc. - DiaSorin S.p.A - Fujirebio Diagnostics, Inc. - Illumina - LabCorp - Luminex Corporation - Menarini Diagnostics - Myriad Genetics - PerkinElmer, Inc. (PE) - Quest Diagnostics - Quidel Corporation - Randox Laboratories Ltd. - TOSOH Corporation - Wako Pure Chemical Industries And hundreds of other companies... For more information visit http://www.researchandmarkets.com/research/x2..._worldwide
MYGN: 34.03 (+0.40), ALR: 43.40 (-0.40), DHR: 86.81 (+0.21), LMNX: 15.45 (+0.02), ERB: 3.45 (-0.09), PKI: 46.30 (-0.10), DGX: 71.68 (+0.03), CPHD: 59.62 (+0.72), QGEN: 23.68 (-0.06), HOLX: 30.46 (+0.21)
Hematology Instruments and Reagents - 2014 Global Strategic Business Report
M2 - Thu Aug 21, 2:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz4292/hematology) has announced the addition of the "Hematology Instruments and Reagents - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Hematology Instruments and Reagents in US$ Thousands by the following Product Segments: - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, & Hematology Vials) - Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, & Hematology Stains). The report profiles 78 companies including many key and niche players such as: - Abbott Diagnostics, Inc. - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Drucker Diagnostics - Horiba Ltd. - Instrumentation Laboratory, Inc. - Mindray Medical International Limited - Roche Diagnostics - Siemens Healthcare - Sigma-Aldrich Corporation - Stago - Sysmex Corporation - Sysmex America, Inc. - Tcoag Ireland Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview & Trends 3. Competitive Scenario 4. Key Product Segments 5. Blood The All Pervasive Connective Tissue 6. Hematology The Core Idea 8. Blood Testing Developments A Historic Review 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 78 (including Divisions/Subsidiaries 111) - The United States (40) - Japan (10) - Europe (37) - France (7) - Germany (
- The United Kingdom (5) - Italy (3) - Spain (2) - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (22) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/fz4292/hematology SIAL: 138.20 (+0.07), MR: 27.19 (+0.15)
Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report 2014
M2 - Thu Aug 07, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4mlqf7/circulating) has announced the addition of the "Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report" report to their offering. The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The report will also provide a market analysis of the market value, growth rates, market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry players, and the factors influencing the market shares of both the major market suppliers and smaller indigenous manufacturers in local markets. The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models. The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis. Key Topics Covered: Executive Summary Chapter 1: Introduction to the Circulating Nucleic Acid Market Report Chapter 2: Background to Circulating Nucleic Acids Chapter 3: Cancer: A Statistical Analysis of the Disease Incidence and Prevalence Chapter 4: CNA Based Cancer Diagnostics Market: Revenue Analysis Chapter 5: CNA Based Cancer Diagnostics Market: Market Share Analysis Chapter 6: Company Profiles - Abbott Laboratories (Abbott Molecular) - Affymetrix Inc - Autogenomics - Becton Dickinson and Company (BD) - Beckmann Coulter, Inc (Danaher Corporation) - bioM?rieux - Cancer Genetics, Inc - Cepheid - Dako (Agilent) - Epigenomics - Hologic Gen-Probe - Illumina - Ipsogen (Qiagen) - Luminex - MolecularMD - Myriad Genetics Laboratories - Novartis Diagnostics - Ortho-Clinical Diagnostics (The Carlyle Group) - Oxford Gene Technology (OGT) - Qiagen N.V. - Roche - Siemens - Sysmex Corporation - Thermo Fisher Scientific - Ventana (Roche) - For more information visit http://www.researchandmarkets.com/research/4m...irculating
ABT: 46.09 (+0.87), MYGN: 34.03 (+0.40), CPHD: 59.62 (+0.72), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21), CGIX: 7.07 (unch), AFFX: 11.45 (+0.02), NVS: 102.20 (-0.17)
Hematology Analyzers & Reagents Market - Forecasts to 2019
M2 - Wed Jul 30, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gc4hs3/hematology) has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering. The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions. In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Trends 6 Hematology Products and Services Market 7 Global Hematology Market, By End Users 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Bio-Rad Laboratories - Boule Diagnostics Ab - Horiba, Ltd. - Mindray Medical International Limited - Nihon Kohden Corporation - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/gc4hs3/hematology
ABT: 46.09 (+0.87), MR: 27.19 (+0.15)
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer
PR Newswire - Wed Jul 23, 7:44PM CDT
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw's appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation's president and governing board while maintaining his leadership position with Sysmex America.
United States Market for In Vitro Diagnostic Tests Report 2014-2018
M2 - Wed Jul 23, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x885q3/the_united_states) has announced the addition of the "The United States Market for In Vitro Diagnostic Tests" report to their offering. Advanced flow cytometry and microbiology tests will provide more opportunity for manufacturers than POC tests or clinical chemistry test products sold in the United States. A Relative Opportunity Metric is used to assess the segments of clinical lab testing in the world's largest healthcare market. According to the report, Market growth remains robust for U.S. microbiology diagnostics, a group of IVD segments including traditional microbiology (culturing for ID/AST), rapid tests, molecular infectious disease tests, and immunoassay infectious disease tests. Several market drivers exist for microbiology in the United States: hospital investment in microbiology for health-acquired infection (HAI) testing, investment in automated microbiology systems, rising rates of incidence for several sexually transmitted diseases (STDs), and market penetration by higher-priced molecular infectious disease tests. The report also indicates that advanced IVD tests in this study, including molecular assays for non-infectious disease testing, histology, cytology, and flow cytometry. Molecular assays and histology are projected to be the two-fastest growing IVD market segments in the United States through 2018. Tissue analysis or histology in support of cancer diagnosis and treatment is increasingly reliant on immunohistochemical (IHC) reagents and molecular hybridization (ISH/FISH) techniques and represents a fast rising market in the aging United States. The United States is also ground zero for an influx of advanced molecular assays for blood-based cancer testing, circulating tumor cell (CTC) testing, pharmacodiagnostics, and other sequencing-developed tests. The report, The United States Market for In Vitro Diagnostic Tests, contains further detail on the US IVD market including segment markets and forecasts, corporate profiles, and other information. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction To U.S. Health Care Chapter Three: U.S. Ivd Market Analysis Chapter Four: Top Tier U.S. Ivd Market Players - Abbott Diagnostics - Alere - Beckman Coulter - Becton Dickinson - Danaher Corporation - Hologic - Ortho-Clinical Diagnostics / J&J Diabetes Care - QIAGEN - Roche Diagnostics - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x8...ted_states
DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)
In Vitro Diagnostics (POC/Rapid Diagnostics) Global Market - Forecast to 2019
M2 - Mon Jul 21, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8h8cv2/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2019" report to their offering. The Asia-Pacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region. IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth. Roche diagnostics (Basel, Switzerland) is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.), bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and R&D units in China to grow IVD market. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. IVD market by Techniques 5. IVD market by Products 6. IVD market by Applications 7. IVD market by End-users 8. IVD market by Usability 9. Regional Market Analysis 10. Company Developments 11. Major Company Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/8h8cv2/in_vitro
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21)
US Hematology Diagnostics Market to 2017
M2 - Wed Jul 02, 8:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hb8k3j/us_hematology) has announced the addition of the "US Hematology Diagnostics Market" report to their offering. This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician's office laboratories. Key Questions This Study Will Answer: - Is the market growing, how long will it continue to grow, and at what rate? - Are the existing competitors structured correctly to meet customer needs? - How will the structure of the market change over time? Is it ripe for acquisitions? - Which emerging or anticipated companies should be on competitors' radar, and why? - Are the products/services offered today meeting customer needs, or is additional development needed? - Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. Drivers, Restraints, and TrendsTotal Hematology Diagnostics Market 5. Forecast and TrendsTotal Hematology Diagnostics Market 6. Competitive Environment 7. Product Analysis 8. Hematology Analyzers Segment 9. Hematology Reagents Segment 10. The Last Word 11. Appendix Companies Mentioned - Abbott Diagnostics - Beckman Coulter - Biorad - Horiba ABX - Medica - Mindray - Siemens Diagnostics - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/hb...hematology
Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020
M2 - Fri Jun 27, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xm2bw/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020" report to their offering. According to this research report titled "In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020). The IVD market is evolving in the emerging markets due to widespread healthcare awareness and increased spending capabilities of people on healthcare. In addition, high demand of technologically advanced equipment for the early and precise diagnosis of various diseases is further strengthening the market growth in such regions. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL IVD MARKET BY TECHNIQUES CHAPTER 5 GLOBAL IVD MARKET BY PRODUCT TYPE CHAPTER 6 GLOBAL IVD MARKET BY USABILITY CHAPTER 7 GLOBAL IVD MARKET BY APPLICATION CHAPTER 8 GLOBAL IVD MARKET BY END USERS CHAPTER 9 GLOBAL IVD MARKET BY GEOGRAPHY CHAPTER 10 COMPANY PROFILES Companies Mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/9x...l_in_vitro
JNJ: 99.62 (+1.18), BDX: 143.71 (+0.72), ALR: 43.40 (-0.40)
(0)
(0)Scroll down for more posts ▼